Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Bristol-Myers Squibb Company BMY NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
$39.61
-31.8%
Analyst Price Target
$62.73
+8%

Bristol-Myers Squibb Company (BMY) has 12 identified peers for comparison in the Healthcare sector. Peers include ABBV, AMGN, BIIB, CI, CVS, ELV and others.

BMY has a market capitalization of $118.58B, compared to an average peer market cap of $232.45B.

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
 AMGN
AMGN
Amgen Inc.
$350.95
+0.32%
 GILD
GILD
Gilead Sciences, Inc.
$140.45
+1.02%
 PFE
PFE
Pfizer Inc.
$27.13
-0.77%
 GSK
GSK
GSK plc
$59.18
+0.41%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message